Friday, September 21, 2012 11:57:50 AM
With MSLPs growing sales, another company is losing that much market share, so for a dominant company, they're losing probably close to 30-40% of MSLPs total sales. This 40% could be in the $30million range for this year. The other company could easily buy muscle pharm with a 1.8 billion O/S for less than they're losing or a little more to sweeten the deal.
I know MSLP has the possibility of going bankrupt, but I think they've proven they're willing to dilute and dilute some more to stay afloat, and new/old shareholders are willing to take it.
The company is worth so little relative to sales, I don't see how a bigger company is not entertaining the idea.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM